Published in J Physiol Pharmacol on March 01, 2005
NMDA receptors in hippocampal GABAergic synapses and their role in nitric oxide signaling. J Neurosci (2011) 0.96
Paraxanthine: Connecting Caffeine to Nitric Oxide Neurotransmission. J Caffeine Res (2013) 0.89
Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications. Crit Care Res Pract (2012) 0.87
Human chromosome 21 orthologous region on mouse chromosome 17 is a major determinant of Down syndrome-related developmental cognitive deficits. Hum Mol Genet (2013) 0.83
Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition. Mediators Inflamm (2015) 0.82
cGMP Signaling, Phosphodiesterases and Major Depressive Disorder. Curr Neuropharmacol (2011) 0.81
Seizure suppression through manipulating splicing of a voltage-gated sodium channel. Brain (2015) 0.81
Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice. J Neural Transm (Vienna) (2012) 0.81
Effects of YC-1 on learning and memory functions of aged rats. Med Sci Monit Basic Res (2014) 0.80
Sildenafil Can Affect Innate and Adaptive Immune System in Both Experimental Animals and Patients. J Immunol Res (2017) 0.75
Endothelial and Neuronal Nitric Oxide Activate Distinct Pathways on Sympathetic Neurotransmission in Rat Tail and Mesenteric Arteries. PLoS One (2015) 0.75
Dopamine D4 receptors linked to protein kinase G are required for changes in dopamine release followed by locomotor activity after repeated cocaine administration. Exp Brain Res (2015) 0.75
Involvement of NO/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.75
The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging. Brain Res (2008) 0.98
Expression of alpha-synuclein in different brain parts of adult and aged rats. J Physiol Pharmacol (2005) 0.85
Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol Chem Neuropathol (1999) 0.82
Detection of protein oxidation in endothelial cells by fluorescently labelled tyramine. Med Sci Monit (2001) 0.78
Elevated nitric oxide production mediates beta-amyloid-induced mitochondria failure. Pol J Pharmacol (2004) 0.77
Differential effect on inositol-phospholipid hydrolysis, cytosolic-free Ca2+ concentration, protein kinase C activity and protein phosphorylation of 1-oleoyl-2-acetyl-sn-glycerol growth-stimulated ascites tumor cells. Eur J Cell Biol (1988) 0.77
Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex. Neurochem Res (2000) 0.77
Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes. Neurochem Int (2005) 0.76
Pergolide mesylate, a dopaminergic receptor agonist, applied with L-DOPA enhances serum antioxidant enzyme activity in Parkinson disease. Clin Neuropharmacol (2004) 0.76
Inhibition of nitric oxide synthase prevents energy failure and oxidative damage evoked in the brain by lipopolysaccharide. Pol J Pharmacol (2004) 0.75
Metabolism of [14C]arachidonic acid-labeled lipids in quiescent and OAG-stimulated ascites tumor cells. Int J Biochem (1992) 0.75